Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kazuya Ishida

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
American Journal of Clinical Dermatology|February 5, 2017
Molecular Diagnostic Techniques for Onychomycosis: Validity and Potential ApplicationShinichi Watanabe, Kazuya Ishida
Biological & Pharmaceutical Bulletin|March 2, 2006
Pharmacokinetic analysis of transcellular transport of quinidine across monolayers of human intestinal epithelial Caco-2 cellsKazuya Ishida, Mari Takaai, Yukiya Hashimoto
Hypertension Research : Official Journal of the Japanese Society of Hypertension|November 10, 2022
Old story, new twist: reducing salt and increasing potassium intake as a social issue according to the INTERMAP JapanJunichi Yatabe, Kazuya Ishida, Midori Sasaki Yatabe
Clinical and Experimental Nephrology|July 14, 2011
Population pharmacokinetics of mizoribine in adult recipients of renal transplantationKazuya Ishida, Masahiko Okamoto, Michio Ishibashi, et al.
Biological & Pharmaceutical Bulletin|November 6, 2007
Simulation for clinical repeated-dose pharmacokinetic trials applying a peak-and-trough sampling design to estimate oral clearanceKazuya Ishida, Yuichiro Kayano, Masato Taguchi, et al.
Biological & Pharmaceutical Bulletin|March 3, 2009
Involvement of the CYP1A subfamily in stereoselective metabolism of carvedilol in beta-naphthoflavone-treated Caco-2 cellsKazuya Ishida, Masato Taguchi, Teruaki Akao, et al.
Drug Discovery Today|October 19, 2020
Clearance prediction for Amgen molecules against Extended Clearance Classification System (ECCS) and future directionsPrashant Agarwal, Kazuya Ishida, Darren L Reid, et al.
Journal of Bioscience and Bioengineering|May 18, 2010
Characteristic features of InfA-15 monoclonal antibody recognizing H1, H3, and H5 subtypes of hemagglutinin of influenza virus A typeEmi Hifumi, Naoko Fujimoto, Kazuya Ishida, et al.
Biological & Pharmaceutical Bulletin|November 6, 2007
Pharmacokinetic analysis of transcellular transport of levofloxacin across LLC-PK1 and Caco-2 cell monolayersMari Takaai, Hisaki Suzuki, Kazuya Ishida, et al.
Biological & Pharmaceutical Bulletin|October 6, 2007
Stereoselective metabolism of carvedilol by the beta-naphthoflavone-inducible enzyme in human intestinal epithelial Caco-2 cellsKazuya Ishida, Mutsuko Honda, Takako Shimizu, et al.
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
American Journal of Clinical Dermatology|February 5, 2017
Molecular Diagnostic Techniques for Onychomycosis: Validity and Potential ApplicationShinichi Watanabe, Kazuya Ishida
Biological & Pharmaceutical Bulletin|March 2, 2006
Pharmacokinetic analysis of transcellular transport of quinidine across monolayers of human intestinal epithelial Caco-2 cellsKazuya Ishida, Mari Takaai, Yukiya Hashimoto
Hypertension Research : Official Journal of the Japanese Society of Hypertension|November 10, 2022
Old story, new twist: reducing salt and increasing potassium intake as a social issue according to the INTERMAP JapanJunichi Yatabe, Kazuya Ishida, Midori Sasaki Yatabe
Clinical and Experimental Nephrology|July 14, 2011
Population pharmacokinetics of mizoribine in adult recipients of renal transplantationKazuya Ishida, Masahiko Okamoto, Michio Ishibashi, et al.
Biological & Pharmaceutical Bulletin|November 6, 2007
Simulation for clinical repeated-dose pharmacokinetic trials applying a peak-and-trough sampling design to estimate oral clearanceKazuya Ishida, Yuichiro Kayano, Masato Taguchi, et al.
Biological & Pharmaceutical Bulletin|March 3, 2009
Involvement of the CYP1A subfamily in stereoselective metabolism of carvedilol in beta-naphthoflavone-treated Caco-2 cellsKazuya Ishida, Masato Taguchi, Teruaki Akao, et al.
Drug Discovery Today|October 19, 2020
Clearance prediction for Amgen molecules against Extended Clearance Classification System (ECCS) and future directionsPrashant Agarwal, Kazuya Ishida, Darren L Reid, et al.
Journal of Bioscience and Bioengineering|May 18, 2010
Characteristic features of InfA-15 monoclonal antibody recognizing H1, H3, and H5 subtypes of hemagglutinin of influenza virus A typeEmi Hifumi, Naoko Fujimoto, Kazuya Ishida, et al.
Biological & Pharmaceutical Bulletin|November 6, 2007
Pharmacokinetic analysis of transcellular transport of levofloxacin across LLC-PK1 and Caco-2 cell monolayersMari Takaai, Hisaki Suzuki, Kazuya Ishida, et al.
Biological & Pharmaceutical Bulletin|October 6, 2007
Stereoselective metabolism of carvedilol by the beta-naphthoflavone-inducible enzyme in human intestinal epithelial Caco-2 cellsKazuya Ishida, Mutsuko Honda, Takako Shimizu, et al.
Pageof 6